Sign in

BOSTON SCIENTIFIC CORP

BSX

Share price not shown yet: live market data is not connected. Everything below comes from BSX’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
31%
rev growth + FCF margin
Revenue growth
+13.5%
TTM vs prior TTM
FCF margin
17.3%
ROE (TTM)
15.5%
TTM NI ÷ avg equity
Net debt
$12.1B
total debt − cash & ST inv.
Dilution (YoY)
-2.2%
negative = buybacks
SBC / revenue
1.5%
TTM revenue
$21.0B

Revenue

$0B$1B$2B$3B$4B$5BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$5B

EPS (diluted)

$0.00$0.20$0.40$0.60$0.80Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$0.61

Margins

GrossOperating
20%40%60%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’2671%

Net income

$0.0B$0.5B$1.0BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$0.9B

Net margin

5%10%15%20%25%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’2617%

Free cash flow vs. stock-based comp

FCFSBC
$0.0B$0.5B$1.0BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$1.3B

Operating cash flow vs. capex

OCFCapex
$0.0B$0.5B$1.0B$1.5BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$1.5B

R&D vs. SG&A

R&DSG&A
$0.0B$0.5B$1.0B$1.5BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$0.6B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…